Legal & General Group
GEVA

Legal & General Group’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Legal & General Group’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-4,114
Closed -$402K – 2815
2015
Q1 		$402K Buy
4,114
+829
+25% +$87.8K ﹤0.01% 1352
2014
Q4 		$304K Sell
3,285
-164
-5% -$12.9K ﹤0.01% 1375
2014
Q3 		$235K Buy
+3,449
New +$247K ﹤0.01% 1429

Legal & General Group's GEVA Position: Q2 2015 in Review

Legal & General Group sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 4,114 shares — an estimated $402K sold.

Legal & General Group first reported a position in GEVA in Q3 2014 and held it in 3 quarters. The position peaked at $402K in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Legal & General Group reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Legal & General Group sold 4,114 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $402K.
  • Legal & General Group first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q3 2014 and held it in 3 quarters.
  • Legal & General Group's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $402K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Legal & General Group's 13F filing for Q2 2015, filed 31 Jul 2015.